BridgeMD
New treatment option for Infant Conditions
Official title Be Sweet to Babies During Nasolaryngoscopy
ClinicalTrials.gov ID: NCT06641687
What this study is testing
- What it's testing
- The investigators want to know if sugar water containing 24% sucrose is helpful in reducing pain in babies during scopes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 12
You may be able to join if
- Patient \<12 months of age;
- Scheduled for an appointment with Dr. Nikolaus Wolter or Dr. Jennifer Siu, who are Staff Pediatric Otolaryngologists at the Hospital for Sick...
- Requiring flexible nasolaryngoscopy for diagnostic purposes;
- Accompanied by caregivers who provided consent.
You likely can't join if
- Patient \>12 months of age
- Infants \<37 weeks corrected gestational age
- Infants with decreased level of consciousness or delayed neuromuscular development with limited pain response
- Infants who have received acute/urgent /emergent airway assessment such as respiratory distress or a foreign body, etc.
- Infants who have received topical anesthesia (topical decongestant/anesthetic spray)
- Infants with the following conditions, where oral sucrose is contraindicated or ineffective:
See the full eligibility criteria
- Patient \<12 months of age;
- Scheduled for an appointment with Dr. Nikolaus Wolter or Dr. Jennifer Siu, who are Staff Pediatric Otolaryngologists at the Hospital for Sick Children, or Meghan Tepsich, a complex airway Nurse Practitioner at SickKids;
- Requiring flexible nasolaryngoscopy for diagnostic purposes;
- Accompanied by caregivers who provided consent.
- Patient \>12 months of age
- Infants \<37 weeks corrected gestational age
- Infants with decreased level of consciousness or delayed neuromuscular development with limited pain response
- Infants who have received acute/urgent /emergent airway assessment such as respiratory distress or a foreign body, etc.
- Infants who have received topical anesthesia (topical decongestant/anesthetic spray)
- Infants with the following conditions, where oral sucrose is contraindicated or ineffective:
- Carbohydrate intolerance
- Decreased level of consciousness or heavy sedation
- Absent gag reflex
- Non-functional gastrointestinal tract
- History of aspiration, tracheoesophageal fistula
- Necrotizing enterocolitis
- Infants whose parents did not consent to enrolling their child in the study, including randomization into either arm of the study due to preference for a given intervention
- Any other circumstance in which consent for participation in the study was not obtained prior to the scope Infants will also be excluded from the study if they present with conditions in which FNL is contraindicated:
- Severe respiratory distress
- Post-palliative systemic artery to pulmonary artery shunt
- Single ventricle congenital heart disease
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 12 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.